Good news, the University of Oxford vaccine against Covi-19 Coronavirus advances data from its trials and produces an immune response.
During all the tests that have been done around the multiple vaccines against the Coronavirus Covid-19 one of the biggest obsession points is the immune response in older adults.
They are one of the most exposed populations and if each project, like Pfizer’s, works in them to fight the disease, it is the maximum manifestation of their efficiency.
Under this parameter, many laboratories began to show data that supported this effectiveness. But the vaccine Oxford University and AstraZeneca no.
This situation caused some uncertainty, but fortunately that has already changed.
The vaccine works very well in older adults
Since The Lancet The results of the latest Phase 2 trials on this experimental vaccine against the Coronavirus Covid-19 have been published.
In the study published, 560 adults, 240 of whom are over 70 years of age, participated to find that the treatment does generate an immune response.
Volunteers over 55 years old were divided into two groups and received a single dose or two in a period of one month. Period in which the presence of T cells was found at two weeks.
In the end, it was found that the ChAdOx1 nCoV-19 vaccine generated these defenses in a similar way between young and old.
At the same time, there were mild side effects such as fatigue, headache, fever or muscle pain.